CD24 and B-cell non-Hodgkin lymphoma: CD24 is overexpressed in many cancers, including B-cell lymphomas, gliomas, SCLC, HCC, and breast cancer, and appears to be oncogenic.295 CD24 has been demonstrated to be a marker for cancer diagnosis and prognosis.